BioCentury | May 19, 2017
Company News

3SBio acquires China rights to Lilly's Humulin

...tablets and a traditional Chinese medicine (TCM) formulation. It obtained both via its acquisition of Zhejiang Wansheng Pharmaceutical Co. Ltd....
BioCentury | May 17, 2017
Company News

3SBio acquires China rights to Lilly's Humulin

...of Zhejiang Wansheng Pharmaceutical Co. Ltd. in 2015 (see BioCentury Extra, July 24, 2015) . Mary Romeo Bydureon Byetta 3SBio Inc. Eli Lilly and Co. Zhejiang Wansheng Pharmaceutical Co. Ltd. AstraZeneca...
BioCentury | Aug 3, 2015
Company News

Zhejiang Wansheng Pharmaceutical, 3SBio deal

...a recombinant human thrombopoietin (TPO) to treat chemotherapy-induced thrombocytopenia and idiopathic thrombocytopenic purpura (ITP). Zhejiang Wansheng Pharmaceutical Co. Ltd....
BioCentury | Jul 25, 2015
Company News

3SBio acquires Zhejiang Wansheng

...3SBio Inc. (HKSE:1530) will acquire Zhejiang Wansheng Pharmaceutical Co. Ltd. (Hangzhou, China) for RMB528 million ($85.1 million). Zhejiang Wansheng markets...
Items per page:
1 - 4 of 4
BioCentury | May 19, 2017
Company News

3SBio acquires China rights to Lilly's Humulin

...tablets and a traditional Chinese medicine (TCM) formulation. It obtained both via its acquisition of Zhejiang Wansheng Pharmaceutical Co. Ltd....
BioCentury | May 17, 2017
Company News

3SBio acquires China rights to Lilly's Humulin

...of Zhejiang Wansheng Pharmaceutical Co. Ltd. in 2015 (see BioCentury Extra, July 24, 2015) . Mary Romeo Bydureon Byetta 3SBio Inc. Eli Lilly and Co. Zhejiang Wansheng Pharmaceutical Co. Ltd. AstraZeneca...
BioCentury | Aug 3, 2015
Company News

Zhejiang Wansheng Pharmaceutical, 3SBio deal

...a recombinant human thrombopoietin (TPO) to treat chemotherapy-induced thrombocytopenia and idiopathic thrombocytopenic purpura (ITP). Zhejiang Wansheng Pharmaceutical Co. Ltd....
BioCentury | Jul 25, 2015
Company News

3SBio acquires Zhejiang Wansheng

...3SBio Inc. (HKSE:1530) will acquire Zhejiang Wansheng Pharmaceutical Co. Ltd. (Hangzhou, China) for RMB528 million ($85.1 million). Zhejiang Wansheng markets...
Items per page:
1 - 4 of 4